Eden Research Share Discussion Threads

[supersonico] 31/3/2024 07:51

Equity and Inclusion.

Fertility and the Jab.

[supersonico] 30/3/2024 21:56

Canary told you so.. Dominos

[supersonico] 30/3/2024 21:44

Canary told you so..

Tracy Høeg, MD, PhD @TracyBethHoeg

At a pivotal moment, just 9 days after the
@CDC gov recommended the covid vax for adolescents, in May of 2021,
@CDC gov decided NOT to send an already-written alert about the risks of post-mRNA vax myocarditis. Sending it might have changed the entire globe's vaccination strategy, particularly for adolescents & young adults. Many vaccine injuries could have been avoided, even deaths.

As
@ZackStieber & I describe in the article, CDC had plenty of evidence at this point to know the signal was real & had even been fatal.

They chose to hide it.

The CDC prioritized drug manufacturers over Americans' rights to informed consent. They recommended not just 1 but 2 doses of mRNA vaccine for healthy adolescents & young adults, even after they had had Covid- just why? They chose to turn a blind eye and take unnecessary risks with the hearts and lives of young people.

This email is an important find by
@ZackStieber
& is further evidence the CDC is a corrupt agency that we are paying to prioritize the pharmaceutical industry over the health of American people.

[supersonico] 30/3/2024 18:28

Why ESG.

Tom Luongo@TFL1728
The only reason carbon is such an issue for bloodless European colonialists is that they don’t produce any anymore. So, everyone else must suffer.

[kittybiscuits] 30/3/2024 14:42

ha ha ha ha - "so patently obviously highly intelligent and knowledgeable".

Do you really have this high of an opinion on yourself?!

Has it actually occurred to you, the largest shareholder who ever they are, might be so awesomely wealthy, the few million they have dropped on Eden is rather insignificant to them in the grand scheme of things.

[supersonico] 30/3/2024 07:25

Control Grid Blues.. .

ESG Frustration And Backlash In The Banking Sector Continues

[kittybiscuits] 29/3/2024 22:51

I have no doubt sunflower seeds are in the pipeline, (very possibly other seeds as well) but so far even the mighty Corteva has not managed to speed up the approval of Ecovelux. (At least not yet).

Based on the approximate timeline they posted at the launch, I believe this November is the earliest in that range window.

Of course, I hope it’s earlier!

[neutralpov] 29/3/2024 16:56

Hahahaha, the two idiots have "Sunflowers" confused with "Vaccines", wnich the crazy supersonico has on many occasions explained is the target core business, subsidiary only to RNSs, of this fleabitten dawg!

:D

[investingisatrickygame] 29/3/2024 15:05

Well we know Sunflowers is one of the opportunities Eden is working on with Corteva.

[supersonico] 29/3/2024 13:04

Kitty,

You could well be right about the timing but the 'dearth' of product has to be considered and the number of partners involved who can either influence regulatory pace as well as not have a dog in the old fight lobbying for an extension of an incumbent product (as in the case of Korit). These factors in my opinion will contribute positively to the pace of approval and product application in the field particularly in the USA..assuming there is a USA by then.

[kittybiscuits] 29/3/2024 12:28

I do not expect Insecticide sales in 2024 and I reckon you’ll be lucky to see them before the end of 2025.

I know you’ll challenge the point that the active ingredients are the same and already approved and should take less time….feel free to bookmark this post and ridicule me if I’m wrong!

[supersonico] 29/3/2024 11:25

Investing,

What makes you think that when Smith says Eden is working "very actively with them (Corteva) and another partner on the development of seed treatments" (17245) that he is referring to the insecticide?

Abrey commenting on the Insecticide @30 Nov 2023 gives me the impression that they are talking to multiple partners plural not the singular 'partner' mentioned by Smith in the above quote so I'm considering the second seed treatment partner he mentions likely be a different product from that mentioned by Abrey..

Also notable..during this presentation Smith reminds us of the Major players in this market BASF / Bayer / Syngenta ..make of that what you wish.. inference or market information ..

"we would then move into commercial negotiations with those
potential partners and we would look to do distribution agreements with um some
or maybe one or all of those potential partners and it could could be
that it's a global deal it could be Regional or even country by country
it remains to be seen and it depends on the business cases that are put forward
to us but this one we're really excited about it's a big opportunity" (Abrey)

[investingisatrickygame] 29/3/2024 11:14

It was initially stated that insecticide sales could occur in 2023. I believe that is right if you go back and look. Happy to be corrected.

So like Super, I would agree that an announcement(s) have been delayed in regards to an insecticide deal.

[kittybiscuits] 29/3/2024 08:51

Thanks Super. My expectations was 2nd half of the year for a partner announcement. Hopefully the sooner the better as then they can get cracking with regulator approval which we all know always takes an age!

[supersonico] 28/3/2024 16:30

Kitty,

At the Master investors show 2023 Smith refers to 'another partner' @16.40m. My reference to a delay is aimed at this 'another partner' remark and not at the insecticide as I don't know to what pest targets his comments apply.

"we've publicized the fact that we're working very closely with corteva who if you're not familiar with corteva because I think even today it's not a household
name that's the combined agriscience business of DuPont and Dow so when those
two companies merge they form corteva and corteva's sole focus is basically
crop inputs so they're the number one or number two seed producer in the world through their Pioneer brand they're the number one or number two or certainly in
the top five crop protection chemical producer in the world so there are substantial partner we're working very actively with them and another partner
on the development of seed treatments to again expand our overall addressable
Market"

[kittybiscuits] 28/3/2024 15:42

Super - What makes you think the announcement of a deal with the insecticide is being held up? As far as I am aware, they have not yet announced a timeline for that, apart from saying at 2023 AGM it would commence at end of 2023/beginning of 2024

[supersonico] 28/3/2024 15:28

Eden Research plc@edenresearch @CEDROZ

🍅 By partnering with the industry’s largest players, Eden is able to reach a large network of farmers across the globe. In Sicily, Eden was taken back by the large number and scale of farms to which @EastmanChemCo’;s is connected across the small but mighty island!

[neutralpov] 28/3/2024 14:37

WARNING TO PROSPECTIVE MUGGING VICTIMS

The above LOOOONG postage, completely irrelevant to the non-existent prospects of this EDEN hell-hole and dungpit, is designed to deflect prospective ""investors"" (sic) from seeing where committed whistleblowers like me expose that a BOILER ROOM SCAM is operating on this discussion board.

A ruthless unprincipled paid ramper and a trapped idiotic bull, each with hordes of fake IDs, are at work.

Move on - there's far better homes for your hard-earned ££££ than a company that's been carrying on farcically for nearly 30 YEARS without ever declaring a profit let alone distributing a dividend! Its biz appears to be putting out meaningless RNSs promising cake tomorrow.

Send me a PM/DM and I will provide you with contact details for the largest ""investors""..... lol

[supersonico] 28/3/2024 13:51

Is this deal holding up Eden announcing second seed partner? AWGATWT.

Milan-based private equity firm Nextalia is preparing to file a joint bid with rival NB Renaissance for Verisem, two sources close to the matter said, after the Rome government stopped China-owned Syngenta from buying the Italian seed producer.

Under former Prime Minister Mario Draghi, Italy in 2021 prevented an acquisition of Verisem by Syngenta, a Swiss-based pesticides and seeds giant owned by China National Chemical Corporation since a $43 billion takeover in 2017.

Under Italian rules, the government has "golden powers" to veto foreign bids for assets deemed of strategic national interest.

The Chinese bid for Verisem, which owns brands such as Suba Seeds and Condor Seed Production, was the first time that Italy exercised such powers in the agricultural sector.

The sources said the two Italian private equity firms were now preparing to file a joint bid for Verisem by a Dec. 20 deadline. Each investment firm will account for 50% of the bid, one of the sources said.

After initially being in competition for Verisem, Nextalia and NB Renaissance decided to join forces to bid for an asset which the sources said was worth between 160 million euros ($173 million) and 180 million including debt.

Nextalia is a venture founded by former Barclays and Mediobanca investment banker Francesco Canzonieri, with backing from top bank Intesa Sanpaolo and insurer UnipolSAI.

Nextalia's private equity arm manages 800 million euros in assets. The firm also runs closed-end funds that buy impaired loans through another 330-million euro business.

NB Renaissance was created in 2015 when Intesa spun off its private equity business, setting up a partnership with U.S. investment firm Neuberger Berman.

NB Renaissance is currently invested in another agricultural business - Sicit, an Italian maker of biostimulants for agriculture.

Earlier this year, NB Renaissance sold bioplastic firm Novamont to Versalis, the chemical company of Italian energy major Eni. In 2022, it sold Italian fertiliser maker Biolchim to U.S. conglomerate JM Huber Corporation.

[menshiki] 28/3/2024 12:07

The Neuter has evaded his/her/it's handlers again. The sad human habit of imputing ones own motives to others once again in evidence.